Tofersen in Non-SOD1 ALS

NCT07294144 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

ALS (Amyotrophic Lateral Sclerosis)

Interventions

DRUG: Tofersen

Sponsor

Washington University School of Medicine

Collaborators

[object Object]